Central Trust CO Cara Therapeutics, Inc. Transaction History

Central Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 04, 2018	SELL	$17.57 - $23.95 $878 - $1,197	-50 Closed	0 $0
Q2 2018 Jul 09, 2018	BUY	$11.6 - $19.27 $580 - $963	50 New	50 $0
Q4 2017 Jan 23, 2018	SELL	$11.86 - $14.08 $2,965 - $3,520	-250 Closed	0 $0
Q3 2017 Oct 17, 2017	BUY	$12.6 - $16.34 $3,150 - $4,085	250	250 $0

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14.5M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

Stay updated on Central Trust CO with notifications on news.